Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Houttuynia cordata is a traditional Chinese medicine (TCM) derived from the fresh aerial parts of *Houttuynia cordata* Thunb. (Saururaceae). It is commonly formulated as an injection (Houttuynia cordata injection, HCI) or oral preparation. The drug exhibits broad-spectrum antibacterial, antiviral, anti-inflammatory, and immunomodulatory properties, primarily driven by its active volatile oils (such as decanoylacetaldehyde and methyl nonyl ketone) and flavonoids (such as quercitrin). Developed and manufactured by Hunan Zhengqing Pharmaceutical (also referred to as Hunan Zhongqi Pharmaceutical in some contexts), Houttuynia cordata injection is approved in China and included in the National Medical Insurance catalog. It is clinically indicated for the treatment of lung abscesses caused by phlegm-heat congestion, damp-heat urinary tract infections, and carbuncles caused by exuberant pathogenic heat.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Houttuynia cordata (Hunan Zhengqing Pharmaceutical).